Every year, people are encouraged to get flu shots, wash their hands, and cover their mouths to reduce their risk of acquiring and spreading the flu, the common cold, bronchitis, and other acute respiratory infections. But a recent study suggests that preventing acute respiratory illnesses may be as simple as taking probiotics.
A recent study sponsored by Chr. Hansen has determined that if certain strains of probiotics were administered to the U.S. public, healthcare costs related to respiratory infections would decrease by up to $1.4 billion. The study included research from two different independent clinical trials, which was used to help determine whether probiotics would boost the immune systems of study participants to the point that their ability to fight off respiratory illnesses would improve. The rationale is that certain probiotics would increase the number of beneficial bacteria in the gut microbiome, which scientists say may play a role in the immune response. The results of the independent clinical trials indicated that the people who took probiotics experienced substantive shorter durations of respiratory illnesses than the people who took placebos. This was true even for respiratory illnesses with viral origins.
Using an economic model they created, the study’s authors assessed the healthcare savings that would occur if most of the U.S. population used probiotics prophylactically. They concluded that the savings would likely range between $373 million and $1.4 billion. According to a press release by Chr. Hansen, two of its probiotic strains are among the probiotics that performed well in the independent trials.
Insights into the diets of the tiny common fruit fly may help provide understandings into how humans evolved to eat what we eat, according to new research published in Cell Reports and a press release from Kyoto University.
An international team of scientists led by the University of Goettingen has developed a new approach to identifying the genes that control plant traits.
Earth’s soil is becoming more saline, and as it does, growing crops becomes more difficult or impossible. Scientists at Brigham Young University (BYU) may have discovered a way to prevent soil salinity from ruining crops and crop yields.
Research with a mouse model coupled with an analysis of human clinical trial data have suggested that bioactive compound(s) in broccoli and other cruciferous vegetables may reduce the progression of kidney disease in mice and humans with a specific genetic makeup.
A new U.S. Centers for Disease Control and Prevention (CDC) study suggests that nearly one in five (18%) American adolescents aged 12–18 and one in four (24%) young adults aged 19–34 are living with prediabetes.
IFF Health, Shanghai, has announced a strategic partnership for R&D of anti-aging ingredients with By-Health, a Chinese maker of dietary supplements and raw materials.
As competition for the U.S. snacking dollar intensifies, pressure is mounting on the salty snacks category to adapt and diversify in order to maintain its relevance. New product development (NPD) is already reflecting the industry’s push toward added value in both nutrition and taste.
To further increase the understanding of the microbiome’s impact on human health and to accelerate the development of innovative nutritional solutions promoting health and wellbeing, Nestlé has entered into a partnership with the University of California San Diego Center for Microbiome Innovation (CMI).
Short-term increases in sugar consumption could increase the risk of inflammatory bowel disease and have a significant impact on our health, a new study out of the University of Alberta (U of A) suggests.